SWORD Health

Overview
Activities
News
Preventive Healthcare?
Product stageSegments
Expansion
?
Chronic Care Management
?

SWORD Health is a digital healthcare company that provides virtual physical therapy solutions for individuals suffering from acute, chronic, or post-surgical musculoskeletal (MSK) pain. The company claims to be the first company to introduce sensor-based technology to treat patients on a global scale.

In May 2023, SWORD Health launched a comprehensive platform to predict, prevent, and treat pain. This platform integrates various solutions, including 1) On-Call, which provides 24/7 access to clinical pain specialists; 2) Predict, an AI engine that identifies patients at high risk of surgery; 3) Thrive, its Digital Physical Therapy solution; 4) Bloom, a solution for women's pelvic health conditions; 5) Move, a personalized exercise program; and 6) The Academy, an educational resource for pain management.

Its core solution, Digital Physical Therapy, pairs patients with a physical therapist and a digital therapist. During a physical therapy session, patients wear the company’s FDA-approved motion sensors and can access their AI-powered therapeutic exercise program via a tablet. This allows therapists to provide feedback and track members’ progress in real time. Furthermore, in June 2024, the company launched Phoenix, an AI-based care specialist designed to interact with patients and guide them during sessions.

In October 2021, it acquired Vigilant Technologies, a wearable shirt collar device manufacturer that uses haptic feedback to improve posture and teach users how to prevent soft tissue injuries in the workplace before they occur.

Key customers and partnerships

The company partners with health plans, health systems, and employers in the US, Europe, and Australia. In October 2023, the company partnered with Teladoc Health to provide a broader range of AI-based virtual care services to Teladoc’s clients.

Funding and financials

In June 2024, the company secured USD 130 million in a funding round valuing the company at USD 3 billion, marking a 50% increase from its Series D valuation. The funds were used toward providing liquidity for employees and early investors and expanding AI Care into new markets and categories.

HQ location:
53-55 West 21st Street New York NY USA
Founded year:
2015
Employees:
501-1,000
IPO status:
Private
Total funding:
USD 453.5 mn
Last Funding:
USD 30.0 mn (Series E; Jun 2024)
Last valuation:
USD 3.0 bn (Jun 2024)
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.